Slide Presentations: Wednesday, November 3, 2010 |

Endobronchial Ultrasound-Guided Miniforceps Biopsy of Mediastinal and Hilar Lymph Node Stations FREE TO VIEW

Ara Chrissian, MD; David Misselhorn, RRT; Alexander C. Chen, MD
Author and Funding Information

Washington University School of Medicine, St. Louis, MO

Chest. 2010;138(4_MeetingAbstracts):945A. doi:10.1378/chest.10206
Text Size: A A A
Published online


PURPOSE: Endobronchial ultrasound (EBUS) has significantly increased the diagnostic yield of transbronchial needle aspiration (TBNA) for centrally located thoracic abnormalities, particularly in cases of non-small cell lung carcinoma. EBUS-miniforceps biopsy (MFB) is a technique used to obtain core biopsy specimens for histopathologic examination using the convex probe EBUS bronchoscope. The diagnostic yield of EBUS-MFB has not been prospectively studied for mediastinal and hilar lymph node stations.

METHODS: Patients presenting with mediastinal and/or hilar lymphadenopathy in the absence of pulmonary parenchymal lesions underwent EBUS-TBNA followed by EBUS-MFB of involved lymph node stations. The feasibility, safety, and diagnostic yield of EBUS-MFB following EBUS-TBNA were prospectively evaluated.

RESULTS: A total of 49 paratracheal, subcarinal, and hilar lymph nodes in 33 patients were sampled. A diagnosis was obtained in 44/49 (90%) lymph nodes with EBUS-MFB and 40/49 (82%) lymph nodes with EBUS-TBNA. This difference in yield did not reach statistical significance (p=.206). Combining TBNA and MFB resulted in a diagnosis in 47/49 (96%) of lymph nodes sampled. Per patient, a diagnosis was made in 30/33 (91%) patients with EBUS-MFB, in 29/33 (88%) patients with EBUS-TBNA, and in 32/33 (97%) patients when the two techniques were combined. In cases of lymphoma, EBUS-TBNA was non-diagnostic in 3/3 (0%) lymph nodes and EBUS-MFB was diagnostic in 3/3 (100%) lymph nodes. There were no complications directly related to either MFB or TBNA.

CONCLUSION: EBUS-miniforceps biopsy is a safe and effective method to obtain histopathologic core specimens from mediastinal and hilar lymph node stations. EBUS-MFB appears as effective as EBUS-TBNA for the diagnosis of mediastinal and hilar abnormalities and the combination of the two methods may be superior to either method alone. EBUS-MFB may also be superior to EBUS-TBNA for the diagnosis of lymphoma.

CLINICAL IMPLICATIONS: EBUS-miniforceps biopsy may complement and improve the diagnostic yield of EBUS-TBNA and should be considered when evaluating patients with mediastinal and hilar lymphadenopathy in the absence of pulmonary parenchymal lesions, particularly in cases in which lymphoma is a consideration.

DISCLOSURE: Ara Chrissian, No Financial Disclosure Information; No Product/Research Disclosure Information

2:15 PM - 3:45 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Advanced breast cancer. Diagnosis and treatment.
National Collaborating Centre for Cancer | 9/18/2009
Heavy menstrual bleeding.
National Collaborating Centre for Women's and Children's Health | 7/2/2009
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543